Catalyst Wire Dossier Catalyst Wire Dossier

Pulmonary Artery Denervation (PADN)

Pulmonary Artery Denervation · Pulnovo Medical (Wuxi) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pulmonary Artery Denervation (PADN), covering 2025-06-26 to 2025-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Real-World Study of PADN for the Treatment of PAH

See pricing